InvOpps IV US L.P. 13D/13G Filings for Oyster Point Pharma, Inc. (OYST)

InvOpps IV US L.P. 13D and 13G filings for Oyster Point Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-01-05
4:32 pm
Sale		 2023-01-03 13D Oyster Point Pharma, Inc.
OYST		 InvOpps IV US L.P. 0
0.000%		 -2,768,586decrease
(Position Closed)		 Filing
2022-12-20
5:41 pm
Purchase		 2022-12-13 13D Oyster Point Pharma, Inc.
OYST		 InvOpps IV US L.P. 2,768,586
10.300%		 2,768,586increase
(New Position)		 Filing